In late February 2026, a research study by Dr Nguyen Van Te (Head of Nuclear Medicine at FV Hospital) and his colleagues was officially published in the Journal of Health and Ageing (Thong Nhat Hospital). The report highlights the successful diagnosis of ATTR cardiac amyloidosis in an 80-year-old male patient suffering from heart failure and multiple comorbidities. The report has attracted attention because it describes the successful diagnose using conventional methods.
Dr Nguyen Van Te: An expert in diagnosing “hard-to-detect” heart conditions
Cardiac amyloidosis is a condition caused by the deposition of abnormal insoluble proteins build up in the in the extracellular spaces of the heart, gradually affecting the heart’s ability to function properly. Because the symptoms are often unclear and can resemble other cardiovascular diseases, this rare but serious condition remains challenging to diagnose and treat. Beyond the heart, amyloidosis may also affect the nervous system, lungs, digestive system, liver, kidneys and thyroid gland.

Dr Nguyen Van Te is a nuclear medicine specialist with more than 35 years of experience
In the published report, Dr Nguyen Van Te and his colleagues demonstrated the value of combining different imaging techniques can help doctors accurately diagnose the disease without the need for an invasive heart biopsy. These techniques include electrocardiography (ECG), echocardiography, cardiac MRI (CMRI), and cardiac PYP scan using the radioactive tracer technetium-99m.
Dr Nguyen Van Te explained that the cardiac PYP scan is a safe and non-invasive diagnostic technique. It has a sensitivity of more than 85% and a specificity of up to 99% in distinguishing between the AL and ATTR forms of amyloidosis. “For the ATTR form, this scan can completely replace an invasive heart biopsy,” Dr Te said. “It helps reduce costs for patients, requires no complicated preparation, and can be performed at any time.”
However, due to limited access to advanced equipment, cardiac PYP scans are still not widely available for cardiovascular diagnosis in Vietnam and many other countries.
Clinical capabilities of FV Hospital’s Nuclear Medicine Department
FV Hospital’s Nuclear Medicine Department is among the pioneers in Ho Chi Minh City and southern Vietnam in offering specialised cardiac PYP scans for the diagnosis of ATTR cardiac amyloidosis. By following international protocols, the medical team can help detect the disease at an early stage, particularly in older patients showing signs of heart failure related to restrictive cardiomyopathy.
FV Hospital’s advanced Siemens Symbia Intevo Excel SPECT/CT system plays a key role in the diagnosis of cardiac amyloidosis by combining functional imaging (SPECT) with anatomical imaging (CT). The system optimises bone scintigraphy using radiotracers, enabling the early detection of ATTR amyloid deposits without the need for an invasive myocardial biopsy.
The system also incorporates advanced technologies such as Flash 3D, which can reduce the required radiotracer dose by up to 50%, and CARE Dose4D™, which automatically adjusts X-ray exposure according to each patient’s body characteristics. These features help minimise radiation exposure while maintaining high-quality image resolution for accurate lesion assessment and quantification.
The Nuclear Medicine Department’s contribution represents an important step forward in multidisciplinary cardiac care at FV Hospital, creating a seamless and patient-centred treatment journey. Advanced imaging technology in the Nuclear Medicine Department plays a key role in providing accurate diagnostic results from the outset. Patients are then referred to the Cardiology and Interventional Cardiology Department for a personalised treatment and follow-up plan. Cardiologists work closely with clinical nutritionists to support patients in managing their lifestyle, diet and medications safely and effectively.

The advanced SPECT/CT system delivers faster scan times while using lower radiation doses.
This multidisciplinary approach helps optimise treatment outcomes not only for cardiac amyloidosis, but also for other chronic cardiovascular conditions such as hypertension, high cholesterol and heart failure. By combining advanced medical technology with close collaboration across specialties, FV provides patients with seamless care – from early diagnosis to long-term treatment and recovery.
The newly published research paper highlights the expertise of Dr Nguyen Van Te and his colleagues, while also reflecting FV Hospital’s ongoing commitment to investing in advanced diagnostic technologies and improving the quality of cardiac care in Vietnam.
Related News
See moreRelated News
CO2 Angiography: A breakthrough in protecting patients with severe kidney disease
Representatives from FV Hospital recently presented the topic “The Use of CO₂ in Angiography and Endovascular Interventions” at a scientific conference held at Bach Mai Hospital in Hanoi. In addition to serving as a speaker, Dr Luong Ngoc Trung is also the pioneer in Vietnam in applying this breakthrough technique. The forum focused on the […]
Tumour Removal and Breast Reconstruction in a Single Endoscopic Procedure: A “2-in-1” Solution for Breast Cancer Patients
Early detection of breast cancer offers a high chance of a cure, but the fear of changes to physical appearance remains a major concern for many women. FV Hospital has recently achieved an excellent clinical and cosmetic outcome for a patient with Stage I breast cancer, thanks to a smooth multidisciplinary approach. Following a standard […]
FV HOSPITAL APPLIES FLEXIBLE NASOPHARYNGOSCOPY BIOPSY FOR EARLY DIAGNOSIS OF THROAT AND LARYNX CANCER.
FV’s Otorhinolaryngology (ORL or ENT) Department has implemented the flexible nasopharyngoscopy biopsy to assist in diagnosing cancer in the throat, larynx, tongue base, and vocal cords. This technique offers several advantages: it’s minimally invasive, safe, and cost-effective for patients. Importantly, FV Hospital is a pioneer among specialised multi-disciplinary hospitals in applying this technique. The Olympus […]
Personalised Lung Cancer Treatment: From Genomic Technologies to Robotic Surgery
Lung cancer treatment is entering a new era of personalised care. By analysing the genetic and molecular characteristics of each tumour, doctors at FV Hospital can design treatment plans tailored to each patient, moving beyond the traditional one-size-fits-all approach to care. Mapping tumour biology: Identifying the right target for treatment In the past, patients with […]